Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome

Author(s):  
Juan F. Masa ◽  
Iván D. Benítez ◽  
Shahrokh Javaheri ◽  
Maria Victoria Mogollon ◽  
Maria Á. Sánchez-Quiroga ◽  
...  
2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Scott E. Friedman ◽  
Bruce W. Andrus

Pulmonary hypertension (PH) is a potentially life-threatening condition arising from a wide variety of pathophysiologic mechanisms. Effective treatment requires a systematic diagnostic approach to identify all reversible mechanisms. Many of these mechanisms are relevant to those afflicted with obesity. The unique mechanisms of PH in the obese include obstructive sleep apnea, obesity hypoventilation syndrome, anorexigen use, cardiomyopathy of obesity, and pulmonary thromboembolic disease. Novel mechanisms of PH in the obese include endothelial dysfunction and hyperuricemia. A wide range of effective therapies exist to mitigate the disability of PH in the obese.


2014 ◽  
Vol 20 (10) ◽  
pp. S159-S160
Author(s):  
Kiyoshi Takasu ◽  
Hiroki Matsumoto ◽  
Hiroki Nishiyama ◽  
Takatoshi Kasai ◽  
Tetsuro Miyazaki ◽  
...  

2017 ◽  
Vol 9 (7) ◽  
pp. E658-E659 ◽  
Author(s):  
Aljohara S. Almeneessier ◽  
Samar Z. Nashwan ◽  
Mostafa Q. Al-Shamiri ◽  
Seithikurippu R. Pandi-Perumal ◽  
Ahmed S. BaHammam

2017 ◽  
Vol 9 (3) ◽  
pp. 779-788 ◽  
Author(s):  
Aljohara S. Almeneessier ◽  
Samar Z. Nashwan ◽  
Mostafa Q. Al-Shamiri ◽  
Seithikurippu R. Pandi-Perumal ◽  
Ahmed S. BaHammam

2015 ◽  
Vol 51 (6) ◽  
pp. 304-305 ◽  
Author(s):  
E. Ojeda Castillejo ◽  
P. de Lucas Ramos ◽  
P. Resano Barrios ◽  
S. López Martín ◽  
P. Rodríguez Rodríguez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document